Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.24.1.1.u2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net loss $ (17,031) $ (14,901)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 61 115
Amortization of right-of-use assets 191 182
Unrealized loss on investment 1 4
Share-based compensation expense 376 325
Changes in operating assets and liabilities:    
Trade and other receivables 0 (50)
Prepaid and other assets 1,051 (14)
Trade and other payables (602) 580
Accrued employee benefits 48 30
Lease liabilities (205) (188)
Net cash used in operating activities (16,110) (13,917)
Cash flows from investing activities:    
Purchase of property and equipment (179) 0
Net cash used in investing activities (179)  
Cash flows from financing activities:    
Proceeds from issuance and exercise of common stock, pre-funded warrants, Series 2 warrants, and common warrants 30,922 17,884
Shares and pre-funded warrant issuance costs (2,964) (1,869)
Net cash provided by financing activities 27,958 16,015
Effects of exchange rate changes on cash, cash equivalents, and restricted cash (3) 391
Net increase in cash, cash equivalents, and restricted cash 11,666 2,489
Cash, cash equivalents, and restricted cash, beginning of period 2,490 4,076
Cash, cash equivalents, and restricted cash, end of period $ 14,156 $ 6,565